Literature DB >> 407866

[Incidence and evaluation of the risk of coronary disease. Prospective study in Paris].

J L Richard, P Ducimetière, G Bonnaud, J R Claude, J Lellouch, D Schwartz, J Di Mattéo.   

Abstract

The Paris prospective study in an epidemiological study of 7,453 middle-aged men born in France, and initially free from ischaemic heart disease. The current mean follow-up time is 4 years. The mean annual incidence is 5.1 per 1000, which is about one half that found in similar american studies. This incidence is related to the cholesterol level, to the blood pressure, to cigarette consumption when the smoke is inhaled, to diabetes mellitus, and to major abnormalities on the electrocardiogram. These five factors are mutually independant in their prediction of the risk of future illness. A formula has been derived by statistical analysis, and takes these five factors into account: the incidence of illness rises exponentially as a function of this formula. New cases of ischaemic heart disease are distributed, but with a very patchy incidence, in this population, of which only a very small number remain disease-free. A table has been drawn up to show the probability of a middle aged male contracting ischeamic heart disease within 4 years, and takes the 5 factors into account: this probability varies between 0.5 per cent and 34 per cent.

Entities:  

Mesh:

Year:  1977        PMID: 407866

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  6 in total

1.  A mathematical model for the determination of the optimum value of the treatment threshold for a continuous risk factor.

Authors:  M Cucherat; J P Boissel
Journal:  Eur J Epidemiol       Date:  1998-01       Impact factor: 8.082

2.  Autres pays, autres moeurs.

Authors:  H Tunstall-Pedoe
Journal:  BMJ       Date:  1988-12-17

3.  Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population.

Authors:  P Ducimetiere; E Eschwege; L Papoz; J L Richard; J R Claude; G Rosselin
Journal:  Diabetologia       Date:  1980-09       Impact factor: 10.122

4.  The Paris Cardiovascular Risk Factor Prevention Trial. Effects of two years of intervention in a population of young men.

Authors:  F Cambien; J L Richard; P Ducimetiere; J M Warnet; J Kahn
Journal:  J Epidemiol Community Health       Date:  1981-06       Impact factor: 3.710

5.  Nicotine regulates collagen gene expression, collagenase activity, and DNA synthesis in cultured cardiac fibroblasts.

Authors:  R J Tomek; S Rimar; M Eghbali-Webb
Journal:  Mol Cell Biochem       Date:  1994-07-27       Impact factor: 3.396

6.  Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study.

Authors:  Jianhua Wu; Shihua Zhu; Guiqing Lily Yao; Mohammed A Mohammed; Tom Marshall
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.